Spontaneous Tumor Regression in a Syngeneic Rat Model of Liver Cancer: Implications for Survival Studies

Overview

Journal J Vasc Interv Radiol

Specialties Cardiology & Vascular Diseases
Radiology

Date 2012 Nov 27

PMID 23177115

Citations 18

Authors

Manon Buijs

Jean-Francois H Geschwind

Labiq H Syed

Shanmugasundaram Ganapathy-Kanniappan

Rani Kunjithapatham

Joost W Wijlemans

Byung Kook Kwak

Shinichi Ota

Mustafa Vali

Affiliations

Soon will be listed here.

Abstract

Purpose: To characterize tumor growth of N1S1 cells implanted into the liver of Sprague-Dawley rats to determine if this model could be used for survival studies. These results were compared with tumor growth after implantation with McA-RH7777 cells.

Materials And Methods: N1S1 or McA-RH7777 cells were implanted into the liver of Sprague-Dawley rats (n = 20 and n = 12, respectively) using ultrasound (US) guidance, and tumor growth was followed by using US. Serum profiles of 19 cytokines were compared in naive versus tumor-bearing rats.

Results: Both types of tumors were visible on US 1 week after tumor implantation, but the mean tumor volume of N1S1 tumors was larger compared to McA-RH7777 tumors (231 mm(3) vs 82.3 mm(3), respectively). Tumor volumes in both groups continued to increase, reaching means of 289 mm(3) and 160 mm(3) in N1S1 and McA-RH7777 groups, respectively, 2 weeks after tumor implantation. By week 3, tumor volumes had decreased considerably, and six tumors (50%) in the McA-RH7777 had spontaneously regressed, versus two (10%) in the N1S1 group. Tumor volumes continued to decrease over the following 3 weeks, and complete tumor regression of all tumors was seen 5 weeks and 6 weeks after tumor implantation in the McA-RH7777 and N1S1 groups, respectively. In an N1S1-implanted rat, multiple cytokines that have been shown to correlate with the ability of the tumor to survive in a hostile environment were increased by as much as 50%, whereas the average increase in cytokine levels was 90%. These findings suggest that the net cytokine environment favors an antitumor immune response. A similar trend was observed in a rat with a McA-RH7777 tumor, and the increase in cytokine levels was considerably more pronounced, with an average increase of 320%.

Conclusions: The model of N1S1 cell implantation in the liver of Sprague-Dawley rats is not ideal for survival studies and should only be used with great caution in short-term studies that involve cancer therapies.

Citing Articles

The diagnositic value of dynamic contrast-enhanced ultrasound for evaluation of tissue oxygen status in rat hepatoma model.

Jiang B, Song L, Fei X, Zhu J, Zhu L, Li Q BMC Gastroenterol. 2024; 24(1):424.

PMID: 39578733 PMC: 11585086. DOI: 10.1186/s12876-024-03523-1.

Transarterial Embolization Enhances Programmed Cell Death Ligand 1 Expression and Influences CD8T Lymphocytes Cytotoxicity in an Orthotopic Hepatocellular Carcinoma Rat Model.

Zhang S, Xu L, Li J, Du M, Yin Y, Zhong B Cardiovasc Intervent Radiol. 2024; 47(10):1372-1381.

PMID: 39103638 DOI: 10.1007/s00270-024-03813-x.

Effects of sinomenine on a rat orthotopic liver carcinoma model.

Zhang Y, Ran H, Hui S, Qian L Histol Histopathol. 2023; 39(6):795-804.

PMID: 38084512 DOI: 10.14670/HH-18-683.

Non-Viral Gene Delivery to Hepatocellular Carcinoma via Intra-Arterial Injection.

Vaughan H, Zamboni C, Luly K, Li L, Gabrielson K, Hassan L Int J Nanomedicine. 2023; 18:2525-2537.

PMID: 37197026 PMC: 10184850. DOI: 10.2147/IJN.S390384.

Comparison of Biomarkers Between Hepatic Tumors in Rat Models and a Dog.

Kim S, Kim Y, Kim S, Kim H In Vivo. 2023; 37(1):252-261.

PMID: 36593028 PMC: 9843797. DOI: 10.21873/invivo.13075.

References

Garin E, Denizot B, Roux J, Noiret N, Lepareur N, Moreau M . Description and technical pitfalls of a hepatoma model and of intra-arterial injection of radiolabelled lipiodol in the rat. Lab Anim. 2005; 39(3):314-20. DOI: 10.1258/0023677054307051. View

Thompson S, Callstrom M, Knudsen B, Anderson J, Carter R, Grande J . Development and preliminary testing of a translational model of hepatocellular carcinoma for MR imaging and interventional oncologic investigations. J Vasc Interv Radiol. 2012; 23(3):385-95. PMC: 3904802. DOI: 10.1016/j.jvir.2011.11.018. View

Bar-Yehuda S, Stemmer S, Madi L, Castel D, Ochaion A, Cohen S . The A3 adenosine receptor agonist CF102 induces apoptosis of hepatocellular carcinoma via de-regulation of the Wnt and NF-kappaB signal transduction pathways. Int J Oncol. 2008; 33(2):287-95. View

Ju S, McLennan G, Bennett S, Liang Y, Bonnac L, Pankiewicz K . Technical aspects of imaging and transfemoral arterial treatment of N1-S1 tumors in rats: an appropriate model to test the biology and therapeutic response to transarterial treatments of liver cancers. J Vasc Interv Radiol. 2009; 20(3):410-4. DOI: 10.1016/j.jvir.2008.12.408. View

Newell P, Villanueva A, Friedman S, Koike K, Llovet J . Experimental models of hepatocellular carcinoma. J Hepatol. 2008; 48(5):858-79. PMC: 2990959. DOI: 10.1016/j.jhep.2008.01.008. View

Guo Y, Jin N, Klein R, Nicolai J, Yang G, Omary R . Gas challenge-blood oxygen level-dependent (GC-BOLD) MRI in the rat Novikoff hepatoma model. Magn Reson Imaging. 2011; 30(1):133-8. PMC: 3232318. DOI: 10.1016/j.mri.2011.09.007. View

Vesely M, Kershaw M, Schreiber R, Smyth M . Natural innate and adaptive immunity to cancer. Annu Rev Immunol. 2011; 29:235-71. DOI: 10.1146/annurev-immunol-031210-101324. View

Chen W, Chen C, Liao J, Mao F . Chromium attenuates hepatic damage in a rat model of chronic cholestasis. Life Sci. 2015; 84(17-18):606-14. View

NOVIKOFF A . A transplantable rat liver tumor induced by 4-dimethylaminoazobenzene. Cancer Res. 1957; 17(10):1010-27. View

10.

Tsujimoto T, Kuriyama S, Yamazaki M, Nakatani Y, Okuda H, Yoshiji H . Augmented hepatocellular carcinoma progression and depressed Kupffer cell activity in rat cirrhotic livers. Int J Oncol. 2000; 18(1):41-7. DOI: 10.3892/ijo.18.1.41. View

11.

Luo T, Hsieh B, Wang S, Lin W, Lee T, Shen L . Preparation and biodistribution of rhenium-188 ECD/Lipiodol in rats following hepatic arterial injection. Nucl Med Biol. 2004; 31(5):671-7. DOI: 10.1016/j.nucmedbio.2004.02.005. View

12.

Becker S, Ardisson V, Lepareur N, Sergent O, Bayat S, Noiret N . Increased Lipiodol uptake in hepatocellular carcinoma possibly due to increased membrane fluidity by dexamethasone and tamoxifen. Nucl Med Biol. 2010; 37(7):777-84. DOI: 10.1016/j.nucmedbio.2010.03.013. View

13.

Babsky A, Ju S, Bennett S, George B, McLennan G, Bansal N . Effect of implantation site and growth of hepatocellular carcinoma on apparent diffusion coefficient of water and sodium MRI. NMR Biomed. 2011; 25(2):312-21. DOI: 10.1002/nbm.1752. View

14.

Smyth M, Dunn G, Schreiber R . Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Adv Immunol. 2006; 90:1-50. DOI: 10.1016/S0065-2776(06)90001-7. View

15.

MORRIS H, VELAT C, Wagner B, DAHLGARD M, RAY F . Studies of carcinogenicity in the rate of derivatives of aromatic amines related to N-2-fluorenylacetamide. J Natl Cancer Inst. 1960; 24:149-80. View

16.

Radoja S, Rao T, Hillman D, Frey A . Mice bearing late-stage tumors have normal functional systemic T cell responses in vitro and in vivo. J Immunol. 2000; 164(5):2619-28. DOI: 10.4049/jimmunol.164.5.2619. View

17.

Aravalli R, Golzarian J, Cressman E . Animal models of cancer in interventional radiology. Eur Radiol. 2009; 19(5):1049-53. DOI: 10.1007/s00330-008-1263-8. View

18.

Guo Y, Zhang Y, Klein R, Nijm G, Sahakian A, Omary R . Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocellular carcinoma. Cancer Res. 2010; 70(4):1555-63. PMC: 2822885. DOI: 10.1158/0008-5472.CAN-09-3067. View

19.

Chi K, Wang H, Chen F, Chao Y, Liu R, Chou S . Preclinical evaluation of locoregional delivery of radiolabeled iododeoxyuridine and thymidylate synthase inhibitor in a hepatoma model. J Nucl Med. 2001; 42(2):345-51. View

20.

Grivennikov S, Greten F, Karin M . Immunity, inflammation, and cancer. Cell. 2010; 140(6):883-99. PMC: 2866629. DOI: 10.1016/j.cell.2010.01.025. View